Evidence map›Paper›PMID 27479539›Full record

ReviewThe Analyst2016

Nanoparticles and intracellular applications of surface-enhanced Raman spectroscopy.

Jack Taylor, Anna Huefner, Li Li, Jonathan Wingfield, Sumeet Mahajan

Open access · hybridAbstract readReview
In one paragraph

Review in The Analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Chemical Sensor Nanotechnology in Pharmaceutical Drug Research.Nanomaterials (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jack TaylorDepartment of Chemistry and Institute of Life Sciences (IfLS), University of Southampton, SO17 1BJ, UK. s.mahajan@soton.ac.uk.
Anna HuefnerDepartment of Chemistry and Institute of Life Sciences (IfLS), University of Southampton, SO17 1BJ, UK. s.mahajan@soton.ac.uk and Sector for Biological and Soft Systems, Cavendish Laboratory, Department of Physics, University of Cambridge, 19 JJ Thomson Avenue, Cambridge, CB3 0HE, UK.
Li LiDepartment of Chemistry and Institute of Life Sciences (IfLS), University of Southampton, SO17 1BJ, UK. s.mahajan@soton.ac.uk.
Jonathan WingfieldDiscovery Sciences, Screening and Compound Management, AstraZeneca, Unit 310 - Darwin Building, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
Sumeet MahajanDepartment of Chemistry and Institute of Life Sciences (IfLS), University of Southampton, SO17 1BJ, UK. s.mahajan@soton.ac.uk.
Institute of Life Sciences · INAstraZeneca (United Kingdom) · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-enhanced Raman spectrocopy (SERS) offers ultrasensitive vibrational fingerprinting at the nanoscale. Its non-destructive nature affords an ideal tool for interrogation of the intracellular environment, detecting the localisation of biomolecules, delivery and monitoring of therapeutics and for characterisation of complex cellular processes at the molecular level. Innovations in nanotechnology have produced a wide selection of novel, purpose-built plasmonic nanostructures capable of high SERS enhancement for intracellular probing while microfluidic technologies are being utilised to reproducibly synthesise nanoparticle (NP) probes at large scale and in high throughput. Sophisticated multivariate analysis techniques unlock the wealth of previously unattainable biomolecular information contained within large and multidimensional SERS datasets. Thus, with suitable combination of experimental techniques and analytics, SERS boasts enormous potential for cell based assays and to expand our understanding of the intracellular environment. In this review we trace the pathway to utilisation of nanomaterials for intracellular SERS. Thus we review and assess nanoparticle synthesis methods, their toxicity and cell interactions before presenting significant developments in intracellular SERS methodologies and how identified challenges can be addressed.

Indexed as

NanoparticlesSpectrum Analysis, RamanAnimalsCell LineCytoplasmEndocytosisHumansNanotechnology

Identifiers

PMID27479539
PMCPMC5048737
OpenAlexW2491364693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.